the thymus they undergo apoptosis (1, 2). Recent studies have shown that single amino acid substitutions
demonstrate that the exact self-derivative is unique in its functional activities, i.e., sending a dominant negative signal without significantly decreasing the level of the foreign ligand presented to the TCR. Together, INTRODUCTION these findings support the notion that TCR are selected on precisely matched versions of peptide immunogens Mature T cells encountering peptide:MHC at suffiin the thymus to enable the effect of low-density T cell cient density on peripheral antigen-presenting cells antagonism by such self-peptides within the mature T (APC) are usually stimulated to proliferate and differcell response. entiate into effector cells. By contrast, when thymocytes of the same TCR specificity encounter antigen in 2 Abbreviations used: APL, altered peptide ligand; hCol IV, type IV human collagen; a2(IV), the a2 chain of human collagen type 1 To whom correspondence should be addressed at Division of Biol-IV; SWMb, Sperm whale myoglobin; Hu12, 12-amino-acid minimal peptide from human collagen IV sequence; Mo12, corresponding minogy, Kansas State University, 18 Ackert Hall, Manhattan, KS 66506-4901. Fax: 913-532-6653. E-mail: jsm@ksu.ksu.edu.
imal peptide of the mouse collagen IV sequence.
MATERIALS AND METHODS
cytokine patterns (Th1, Th2, or Th0) as determined by peptide stimulation of IL4, IL2, and IFN-g (see below , I-A b ) mice were purchased from The The assay system has been previously reported (12) . Briefly, Falcon 96-well polyvinyl chloride plates were Jackson Laboratory (Bar Harbor, ME). Mice were used between 8 and 12 weeks of age and experimental coated overnight with capture antibodies at 2.5-4 mg/ ml in 0.1 M NaHCO 3 , pH 8.2. The next day, plates groups were age and sex matched for these studies.
were blocked with 5% FBS-PBS for 1 hr, followed by washing twice in PBS-Tween 20 (0.05% v/v). Th clone Antigens culture supernatants were titrated in triplicate onto Sets of synthetic peptides corresponding to the bio-these blocked wells and incubated along with correlogically active sequences were synthesized by Re-sponding titrations of recombinant standard cytokines search Genetics (Huntsville, AL), and all peptide struc-for 16 hr at 4ЊC. Plates were then incubated with biotintures were confirmed by mass spectrometry (Mass Spec ylated detection antibodies (0.67 mg/ml in 5% FCSLab, University of Kansas, Lawrence, KS). The struc-PBS), followed by avidin-HRPO (5 mg/ml in 5% FBStures of the peptides are shown in Fig. 1 . Peptides were PBS). Finally, the plates were washed six times with biotinylated, as previously described (12), with a short-PBS-Tween and incubated for 10 min with 0.3 mg/ chain NHS-biotin (N-hydroxyl-succinimido-biotin) ml ABTS (2,2-azino-di(3-ethyl-benzthiozaline-sulfonic (Sigma Chemical, St. Louis, MO). To verify biotinyla-acid)) substrate (Cat. No. A-1888, Sigma Chemical), tion and MHC binding, detergent-extracted I-A mole-0.03% (v/v) hydrogen peroxide in 0.1 M citrate buffer, cules were incubated with the biotinylated peptide, pH 4.35. Reaction product was measured as optical subject to SDS-PAGE without boiling, transferred to density at 405 nm with an Emax automatic plate nitrocellulose, and probed with avidin-HRPO as pre-reader (Molecular Devices, Palo Alto, CA). All antibodviously described (13). Densitometry of these blots de-ies and standard cytokines for the ELISAs were purtected bands of appropriate molecular weight corre-chased from PharMingen. sponding to class II MHC as detected in separate lanes with a biotinylated MAb (clone 10-3-6.2, American T Cell Proliferation Assay Type Culture Collection (ATCC), Rockville, MD) (Murray et al., manuscript in preparation).
The assay system has been previously described (12 ]-of peptide emulsified 1:2 in CFA (H37RA, Difco Labora-thymidine (ICN Biochemicals, Irvine, CA) for 18 hr and tories, Detroit, MI). After 10 days, draining lymph cells harvested onto glass fiber filters with a PHD cell nodes were harvested and made into a single-cell sus-harvester (Cambridge Technology, Watertown, MA). pension. T cell cultures and clones were generated as Thymidine incorporation was measured by liquid scindescribed by Hom et al. (14) . Briefly, 5 1 10 6 lymph tillation in a Beckman LS6000 counter and standard node cells were cultured for 4 days in 24-well plates errors were computed. (Corning, Corning, NY) with 10 mM Hu12 peptide in Click's medium (Irvine Scientific, Santa Ana, CA) sup-T Cell Proliferation Antagonism Assay and plemented with 50 mM b-mercaptoethanol (Bio-Rad, Antagonism Index Hercules, CA), containing 5% FBS (Hyclone, Logan, UT). At 4-to 6-day intervals, half of the media were Proliferation assays were set up as above; however, the altered peptides were used as inhibitors of proliferreplaced with Click's containing 5 U/ml human recom- MHC presentation on the APC surface, whereas large tested ( Table 1 ). All of the clones reported here have been in culture for 1-2 years and display consistent indices indicate greater TCR-mediated antagonism.
Peptide Competition Assay for Cell Surface Ligand Density by Flow Cytometry
We used a method previously described to determine whether individual members of the set of altered peptides could compete with the Hu12 agonist for MHC binding on live APC (12, 15) . APC were prepared from groups of three naive animals, and T cells were depleted with a cocktail of monoclonal antibodies [anti-CD8 (TIB-105, 0210, ATCC), anti-CD4 (GK1.5, ATCC), and anti-Thy1 (Y19, Yale University)], followed by Cmediated lysis (LowToxM rabbit complement, Accurate, Westbury, NY). The resulting APC suspension, in HBSS, was then fractionated over lymphocyte separation medium (LSM, Organon Teknika, Rockville, MD) Table 1 ). Interestingly, with multiple self-for-non-self-substiamino acid peptide, which corresponds to amino acids 675-686 in the a2(IV) chain of the hCol IV molecule tution, both I-A genotype clones displayed reactivity similar to that observed with the mouse peptide, Mo12. (16), was identified as the minimal peptide on the basis of the above biologic activity; that is, the C-truncated For example, T12 and E9 had different effects on clones derived from each I-A genotype; however, the ET pep11mer, or the N-truncated 11mer, of this sequence does not elicit the MHC-linked Th1/Th2 response patterns tide with both substitutions was essentially like the Mo12 in that it was nonstimulatory for both sets of Th observed with the 12mer minimal peptide and the whole hCol IV molecule (12) . When compared to se-clones (Fig. 2, Table 1 ). Therefore, with regard to the induction of proliferation (agonist activities), it appears quences in the data bases, the best match is the corresponding sequence of the mouse a2(IV) chain (amino that single changes (T12, V3, V1, and E9) are still able to induce proliferation at a reduced level, which disacids 670-681) (16) (17) (18) . As shown in Fig. 1 , the peptide antigen and the mouse self-correlate share a core motif plays MHC-linked differences in peptide specificity. A slight exception was peptide V2 which exhibited very of seven residues (---Q P G C I-G P-) and peptide V1V3ET, with just a foreign alanine at position peptides of the panel were able to inhibit proliferation at a nominally stimulating dose of the foreign antigenic 2, did not activate proliferation like Hu12. Thus, it was not possible to dissect the sequence into stepwise peptide. Clearly, most members of the panel were not antagonists, and antagonist activity was specific to the changes that explained either the lack of agonist activity by the Mo12 peptide or the induction of proliferation Th1 clone, 3S8 (i.e., other clones, like SW7, were not antagonized by these peptides even though several of at low peptide doses by the Hu12 antigen. Multiple changes (ET, V3T, V3ET, V1V2ET, etc.) did, however, them were partial agonists of proliferation). This suggested true TCR antagonism involving TCR specificity/ render the ligand essentially inactive; similar to the mouse correlate, with regard to the stimulation of T affinity of the Th clone, rather than an antigen nonspecific effect of this particular set of peptide derivatives. cell proliferation (Table 1) . From these data, we predicted that the ability to inhibit T cell proliferation to Importantly, the derivative showing the most antagonist activity (53% inhibition of proliferation) was the the Hu12 peptide would mirror this inactivation as the peptide was changed to self. However, as described in mouse peptide correlate (i.e., where all of the five nonconserved positions of the Hu12 peptide had been the next section, we found that the sensitivity for self was more acute with respect to antagonism than it was switched to the corresponding mouse amino acid). Note that this is not a cumulative effect, as peptide T12 and with respect to Th proliferation.
peptide V3, each with just a single substitution, display more inhibition than peptides like VVVT, which differs Self-Substituted Derivatives of the hCol IV Minimal from the mouse correlate only at position 9 ( Fig. 1 , Peptide Show Antagonism of Th1 Proliferation Table 2 ). Certain partial agonist peptides have been shown to antagonize the responses of Th clones to the wild-type The Mo12 Antagonist Peptide Does Not Compete peptide antigen (3) (4) (5) (6) (7) . Therefore, we co-incubated the Effectively with the Hu12 Agonist Peptide for Cell various derivatives of the peptide antigen (Fig. 1), at Surface Density on the APC increasing doses with a constant (half-maximal) concentration of the human peptide agonist, Hu12. As il-
The relative abilities of the peptide derivatives to compete for MHC binding could explain their relative lustrated by Fig. 3 and in Table 2 , we found that three effects on Th proliferation by a simple competition mechanism (19, 20) . In this model, the agonist ligand density is reduced by that of the antagonist (a peptide:MHC complex to which the TCR has lower affinity), in this case the self-antagonist, Mo12 peptide. Strict adherence to this mechanism would predict that the ability of a given derivative to compete for MHC presentation would be of the order Mo12 úú T12 § V3 úúú all others. However, as is shown in Fig. 4 , it is clear that the Mo12 correlate does not effectively compete with the foreign peptide for binding to the APC. Moreover, peptides like V1, T12, and V3, which were effective MHC competitors, did not as effectively antagonize T cell proliferation.
Therefore, the Mo12 self-peptide appears to be unique in that it does not stimulate proliferation on its own (an expected result), but does most effectively antagonize Th proliferation to the foreign peptide analog of its sequence. Therefore, it follows that the Mo12 derivative must deliver a dominant negative signal, because it does not require significant reduction of the stimulatory ligand density on the APC surface.
TCR-Mediated Antagonism of Th1 Proliferation Shows Fine Specificity for the Exact self-Correlate of the Peptide Antigen
As a means of comparison between the peptide derivatives, we compiled the percentage inhibition data and MHC competition results of all the derivatives tested ( Table 2) . We derived a TCR antagonist index (Ai) as the ratio of these two parameters, respectively, where a larger number reflects the ability of the peptide to antagonize proliferation without significantly decreasing the agonist ligand density. From this analysis (Table 2), it can be seen that the Mo12 peptide is unique in its effect (Ai Å 3.31 versus Ai Å 0.67, for the next highest derivative, V3). Partial agonist peptides like T12 and V3, which compete for MHC presentation, were able to inhibit Th proliferation by 32-33% and these peptides reduced density of the biotinylated agonist peptide by 48-65% in the APC binding assay. However, the inhibition with these peptides was significantly greater than that observed with the SWMb peptide (at 16%) which was a better MHC competitor (at 84%), and SWMb peptide would not likely ligate the TCR on its own. Thus, simple MHC competition does not explain the antagonist effect of partial agonists, but it does suggest that for these peptides the negative signal delivered may result from an Ç50% dilution in the engagements of the TCR with the APL (see below). By contrast, the greater antagonist effect of the self-peptide (Ai Å 3.31) actually requires little reduction in the density of the wild-type peptide; thus, the endogenous APL sends a signal that dominates T cell recognition of the foreign ligand.
FIG. 3.
Antagonism of T cell clones by self-substituted peptides. T cells were incubated with increasing doses of altered peptides as in Fig. 2 ; however, a dosage of Hu12 peptide sufficient to yield approximately one-half maximal proliferation (0.1 mM) was co-incubated in each well. Thymidine incorporation was measured and mean cpm of triplicate wells were calculated with standard deviation.
DISCUSSION
that can antagonize the recall proliferation of mature T cell clones against their respective wild-type peptide T cell recognition and development require specific antigens (3) (4) (5) . Most interestingly, certain antagonist interaction between the TCR a/b and a peptide frag-peptides form ligands that provide the recognition sigment bound to the groove of a self-encoded MHC mole-nal for positive selection during T cell development cule. It has been demonstrated that peptides substi- (3, 7, 10) . Molecular matching between foreign peptides tuted at key amino acid positions generate TCR ligands and self-peptides has been proposed such that reactivity patterns of individual T cell clones may reflect upon previous encounters with the endogenous ligand dur- overall presentation densities of the respective pep-10 clones have been examined; Schountz and Murray, unpublished data). Taken together, our results indicate tide:MHC ligands. We have not been able to identify clones from the I-A b genotype which show antagonism that the ability of the mouse peptide to antagonize the mature T cell response is linked to MHC genotype and by the endogenous Mo12 peptide (to date, a total of to apparent TCR contacts dictated by the C-terminus APL. The present challenge is to determine if this effect is an exploitable by-product of the TCR selection process. of the minimal peptide.
Qualitative differences in the signal delivered by ACKNOWLEDGMENTS APL have been suggested by the work of Sloan-Lancaster et al. 
